查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1972632

周邊置入中央靜脈導管市場：依產品類型、材質、適應症、最終用戶、通路分類，全球預測（2026-2032年）

Peripherally Inserted Central Catheter Market by Product Type, Material, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，周邊置入中央靜脈導管市場價值將達到 13.5 億美元，到 2026 年將成長至 14.3 億美元，到 2032 年將達到 20.9 億美元，複合年成長率為 6.47%。

主要市場統計數據
基準年 2025 13.5億美元
預計年份：2026年 14.3億美元
預測年份 2032 20.9億美元
複合年成長率 (%) 6.47%

全面介紹現代周邊置入中央靜脈導管。

周邊置入的中央靜脈導管如今在急診、長期治療以及不斷發展的門診醫療保健系統中扮演著至關重要的角色。臨床醫生和採購團隊越來越重視器械選擇，認為這是一個多方面的決策，必須兼顧病患安全、手術效率以及與不斷發展的治療和影像工作流程的兼容性。同時，醫院和居家醫療機構也在調整通訊協定，以適應更廣泛的適應症，並專注於縮短住院時間和分散式輸液。

材料創新、器材設計進步以及醫療服務模式的重組如何改變靜脈通路裝置的臨床實務與採購選擇？

由於材料科學的進步、設計創新以及醫療服務體系的重組，周邊置入中央靜脈導管領域正經歷變革。抗菌和抗血栓塗層的最新進展正在改變其臨床風險特徵，而動力注射設計和多腔結構的出現則滿足了複雜的治療方法和影像檢查需求。同時，臨床醫生正在推進手術導引技術和標準化置入流程的整合，以減少併發症並縮短手術時間。

關稅引發的供應鏈重組和採購應對措施的策略影響：對醫療設備供應商、生產基地和臨床可用性的影響

到2025年，一系列關稅調整及相關貿易政策變化帶來的累積效應，為醫療設備的策略採購和供應商管理引入了新的變數。關鍵原料和成品醫療設備的進口關稅凸顯了供應商網路和區域製造地多元化的重要性。因此，採購經理們正在重新評估總到岸成本（TLC），加快雙源採購策略的實施，並透過長期合約進行對沖，以降低波動風險，同時確保臨床關鍵器械的供應連續性。

透過深入的細分分析進行精準定位，將產品設計、材料技術、臨床環境、治療適應症和分銷動態連結起來。

產品系列豐富多樣，涵蓋多種選擇，包括開放式同軸導管、動力注射導管和帶閥同軸導管系統，並提供多腔和單腔配置。這使其能夠滿足從常規輸液到複雜影像引導治療等廣泛的臨床需求。材料的選擇同樣至關重要。聚氨酯和矽膠芯材是主流選擇，均提供標準型和塗層型兩種規格。塗層型導管具有抗菌和抗血栓特性，可降低感染和阻塞的風險，同時也會影響導管的柔軟性和放置性能。

決定靜脈通路裝置。

區域趨勢揭示了美洲、歐洲、中東和非洲以及亞太地區各自獨特的需求促進因素和營運限制因素。每個地區都有其獨特的臨床實務規範、法規結構和供應鏈結構。在美洲，大型醫療保健系統的整合以及對門診靜脈治療日益成長的重視，促使製造商優先研發有助於門診置管、完善的後續護理通訊協定以及顯著降低併發症發生率的醫療器材。這種環境凸顯了完善的臨床醫生培訓計畫和服務水準協議的重要性日益凸顯。

製造商和通路合作夥伴為推動臨床應用和在醫療保健領域實現差異化價值所採取的競爭定位和策略措施。

競爭格局包括成熟的醫療設備製造商和專注於臨床證據、產品可靠性和綜合服務的專業血管通路技術創新公司。主要企業透過投資材料技術、塗層和導管結構來降低手術複雜性和術後併發症，從而實現差異化競爭。策略性併購以及與臨床網路和輸液服務供應商建立有針對性的夥伴關係關係，正成為加速產品推廣和拓展門診及居家照護服務能力的戰術性策略。

製造商、供應商和經銷商為改善臨床結果、增強供應韌性和實現商業性差異化而應採取的切實策略重點。

產業領導者應優先考慮將產品創新、供應鏈韌性和臨床醫生能力提升相結合的協作模式。首先，加速塗層和抗血栓材料的研發和臨床檢驗，可以解決長期存在的安全隱患，並在門診靜脈輸液治療和長期照護領域創造明確的價值提案。其次，實現製造地多元化並採用靈活的生產模式，可以提高對區域需求波動的應對力，同時降低關稅帶來的成本壓力。

為了確保實務見解，我們採用嚴格的混合調查方法，結合臨床醫師的初步訪談、二次技術分析和專家檢驗。

本分析基於調查方法，該方法系統地整合了對臨床醫生、採購經理和行業專家的訪談，以及監管申報文件、臨床文獻和醫療設備技術文件等二手資料。手術醫生和液體管理專家的定性見解與產品規格和材料性能數據進行三角驗證，從而能夠對臨床和營運影響進行可靠的解讀。在條件允許的情況下，也查閱了上市後監測報告和不利事件資料庫，以了解安全性和併發症趨勢的背景資訊。

總之，我們彙編了一套綜合的臨床、營運和策略要求，以指導血管通路設備的選擇、採購和創新。

總之，周邊置入中央靜脈導管的發展軌跡受到多種因素的共同影響，包括材料和設計的創新、向門診和居家醫療的轉變，以及貿易政策導致的供應鏈日益複雜化。投資於經臨床檢驗的塗層技術、靈活的設備配置以及完善的醫護人員培訓的相關人員，最能滿足病患安全和營運效率的雙重需求。策略性的供應鏈重組和區域商業化計畫對於在保持臨床績效標準的同時應對成本壓力至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章周邊置入中央靜脈導管市場：依產品類型分類

  • 開口同軸導管
    • 多流明
    • 單流明
  • 可注入式電源
    • 多流明
    • 單流明
  • 帶閥門的同軸導管
    • 多流明
    • 單流明

第9章周邊置入中央靜脈導管市場：依材質

  • 聚氨酯
    • 抗菌塗層
    • 標準聚氨酯
  • 矽酮
    • 抗血栓塗層
    • 標準矽膠

第10章周邊置入中央靜脈導管市場：依適應症分類

  • 抗生素治療
    • 長期治療
    • 短期治療
  • 化療
    • 血液治療
    • 固態腫瘤的治療
  • 點滴療法
    • 重症監護輸液
    • 水療法
    • 疼痛管理輸液
  • 腸外營養
    • 部分腸外營養
    • 全腸外營養

第11章周邊置入中央靜脈導管市場：依最終用戶分類

  • 門診手術中心
    • 醫院附設中心
    • 獨立中心
  • 透析中心
    • 醫院安裝型
    • 獨立的
  • 居家醫療設施
    • 家庭輸液服務
    • 護理機構
  • 醫院
    • 當地醫院
    • 專科醫院

第12章周邊置入中央靜脈導管市場：依通路分類

  • 醫院藥房
    • 外部藥房
    • 醫院藥房
  • 線上銷售
    • 廠商直銷
    • 經銷平台
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房

第13章周邊置入中央靜脈導管市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章周邊置入中央靜脈導管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章周邊置入中央靜脈導管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國：周邊置入中央靜脈導管市場

第17章 中國：周邊置入中央靜脈導管市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Cook Medical LLC
  • ICU Medical, Inc.
  • Medical Components, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • PFM Medical, Inc.
  • Poly Medicure Ltd.
  • Smiths Group plc
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-9A6A6F2976B4

The Peripherally Inserted Central Catheter Market was valued at USD 1.35 billion in 2025 and is projected to grow to USD 1.43 billion in 2026, with a CAGR of 6.47%, reaching USD 2.09 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.35 billion
Estimated Year [2026] USD 1.43 billion
Forecast Year [2032] USD 2.09 billion
CAGR (%) 6.47%

A comprehensive introduction to the clinical significance, delivery settings, and decision drivers that define contemporary peripherally inserted central catheter use

Peripherally inserted central catheters now occupy a critical intersection between acute care, long-term therapy, and the expanding outpatient ecosystem. Clinicians and procurement teams increasingly view device selection as a multidimensional decision that must balance patient safety, procedural efficiency, and compatibility with evolving therapeutic and imaging workflows. In parallel, hospitals and home care providers are adapting protocols to accommodate broader indications and an increasing emphasis on reduced hospital stays and decentralized infusion delivery.

This introduction establishes the clinical scope, supply chain influences, and the regulatory and reimbursement forces that shape adoption. It sets the stage for a deeper assessment of technological inflections, material science advances, and shifting care delivery models that together determine the trajectory of device development and clinical uptake.

How material innovations, device design advances, and care delivery reconfiguration are reshaping clinical practice and procurement choices for vascular access devices

The landscape for peripherally inserted central catheters is experiencing transformative shifts driven by advances in material science, design innovation, and care delivery reconfiguration. Recent developments in antimicrobial and antithrombogenic coatings are changing clinical risk profiles, while the emergence of power-injectable designs and multi-lumen configurations addresses complex therapeutic regimens and imaging requirements. At the same time, clinicians are integrating procedural guidance technologies and standardized insertion bundles that reduce complications and shorten procedure times.

Concurrently, health systems are altering care pathways to move more infusion and long-term therapies into ambulatory and home-based settings, which accelerates demand for devices optimized for outpatient placement, durability, and maintenance by multidisciplinary teams. Together, these shifts underscore a transition from single-dimension device selection toward a holistic evaluation that includes procedural ecosystem compatibility, lifecycle resource needs, and patient-centered outcomes.

Strategic implications of tariff-driven supply chain realignments and procurement responses that influence device sourcing, production footprints, and clinical availability

The cumulative effect of tariff adjustments and related trade policy changes announced through 2025 has introduced new variables into strategic sourcing and supplier management for medical devices. Import duties on critical raw materials and finished medical devices have amplified the importance of diversified supplier networks and regional manufacturing footprints. As a result, procurement leaders are revisiting total landed cost calculations, accelerating dual-sourcing strategies, and engaging in longer-term contractual hedges to mitigate volatility while preserving supply continuity for clinically critical devices.

In response to these pressures, several manufacturers and distributors have reprioritized regional production and local inventory buffers to reduce exposure to cross-border tariff fluctuations. This reorientation has meaningful implications for lead times, product configuration decisions tied to material substitutions, and the negotiation dynamics between providers and suppliers. Clinicians and supply chain teams must now weigh the trade-offs between near-term cost pressures and the longer-term clinical performance characteristics that influence patient outcomes.

Insightful segmentation analysis bridging product design, material technology, clinical setting, therapeutic indication, and distribution dynamics for precision positioning

The product landscape is multifaceted, encompassing open ended coaxial designs, power-injectable options, and valved coaxial systems with configurations available in multi-lumen and single-lumen variants to address a range of clinical requirements from routine infusions to complex imaging-compatible therapies. Material selection plays a parallel role: polyurethane and silicone core substrates dominate, each available in standard and coated formulations that provide antimicrobial or antithrombogenic properties intended to reduce infection and occlusion risks while influencing catheter flexibility and dwell characteristics.

End-user diversity amplifies segmentation complexity because device specifications must align with the operational realities of ambulatory surgery centers, dialysis centers, home care settings, and hospitals, which themselves include affiliated versus independent centers, hospital-based versus standalone dialysis units, and community versus specialty hospitals. Clinical indications further influence selection criteria, with antibiotic therapy, chemotherapy, infusion therapy, and parenteral nutrition encompassing subtypes such as long-term versus short-term antibiotic regimens, hematological versus solid tumor chemotherapy protocols, and differentiated infusion therapy needs like critical care infusion versus hydration or pain management. Distribution channels-hospital pharmacies, online direct manufacturer or distributor platforms, and retail pharmacies spanning chain and independent outlets-add another dimension of commercialization strategy, impacting product availability, clinician education, and post-market support models.

Regional dynamics and cross-border considerations that determine adoption pathways, regulatory approaches, and distribution strategies for vascular access devices

Regional dynamics reveal differentiated demand drivers and operational constraints across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct clinical practice norms, regulatory frameworks, and supply chain architectures. In the Americas, consolidation among large health systems and an emphasis on outpatient infusion growth push manufacturers to prioritize devices that facilitate ambulatory placement, robust post-insertion care protocols, and demonstrable reductions in complication rates. This environment elevates the importance of strong clinician training programs and service-level agreements.

In Europe, the Middle East & Africa, and the Asia-Pacific regions, regulatory timelines, reimbursement policies, and local manufacturing capacity collectively shape product introduction strategies and commercialization pathways. Organizations operating across these regions must reconcile global design standards with localized needs, balancing centralized R&D with regional adaptation. Consequently, cross-border coordination, regional clinical evidence generation, and strategic partnerships with local distributors or clinical networks are critical to scalable adoption and sustained performance across heterogeneous healthcare ecosystems.

Competitive positioning and strategic levers employed by manufacturers and channel partners to drive clinical adoption and differentiated value across care settings

The competitive environment is populated by established medical device manufacturers and specialized vascular access innovators that emphasize clinical evidence, product reliability, and integrated services. Leading firms are differentiating through investments in material technologies, coatings, and catheter architectures that reduce procedural complexity and post-insertion complications. Strategic M&A and targeted partnerships with clinical networks or infusion service providers have emerged as tactical levers to accelerate product adoption and extend service capabilities into ambulatory and home-based care channels.

Innovators that pair device performance with digital or procedural support-such as clinician training platforms, insertion aids, and post-market surveillance tools-gain preferential access to integrated health systems focused on outcomes-based procurement. Meanwhile, distribution and logistics partners that provide configurable supply arrangements, rapid replenishment, and clinical education services strengthen manufacturer propositions and influence purchasing decisions at the hospital and outpatient levels.

Actionable strategic priorities for manufacturers, providers, and distributors to enhance clinical outcomes, supply resilience, and commercial differentiation

Industry leaders should prioritize a coordinated approach that aligns product innovation with supply chain resilience and clinician enablement. First, accelerating the development and clinical validation of coated and antithrombogenic materials will address persistent safety concerns and create clearer value propositions for outpatient infusion and long-term therapies. Second, diversifying manufacturing footprints and adopting flexible production models can reduce exposure to tariff-driven cost pressures while improving responsiveness to regional demand shifts.

Moreover, investing in clinician training programs, standardized insertion bundles, and post-insertion support services will drive better outcomes and reduce total care burdens. Manufacturers and providers should form collaborative pilot programs to evaluate device performance across relevant end-user settings and indications, ensuring that procurement decisions reflect real-world use cases. Finally, integrating data capture and outcome analytics into product offerings will support value-based negotiations and demonstrate the clinical and operational benefits necessary to secure preferred status with major health systems and payers.

A rigorous mixed-methods research methodology integrating primary clinician interviews, secondary technical analysis, and expert validation to ensure actionable insights

The analysis is grounded in a systematic methodology that synthesized primary interviews with clinicians, procurement leaders, and industry experts alongside secondary sources including regulatory filings, clinical literature, and device technical documentation. Qualitative insights from proceduralists and infusion specialists were triangulated with product specifications and materials performance data to ensure robust interpretation of clinical and operational implications. Where available, post-market surveillance reports and adverse event databases were reviewed to contextualize safety and complication trends.

To enhance rigor, the research applied an iterative validation process with subject-matter experts to reconcile divergent perspectives and refine key assumptions. Limitations include variable transparency in supplier cost components and incomplete disclosure of proprietary clinical registry outcomes, which were mitigated through cross-referenced interviews and independent technical assessments. The result is a disciplined synthesis designed to inform strategic decisions without relying on opaque or single-source inputs.

Concluding synthesis of clinical, operational, and strategic imperatives that will guide device selection, procurement, and innovation for vascular access

In conclusion, the trajectory of peripherally inserted central catheters is being shaped by convergent forces-material and design innovation, evolving care delivery into ambulatory and home settings, and heightened supply chain complexity driven by trade policies. Stakeholders who invest in clinically validated coatings, flexible device configurations, and robust clinician education will be best positioned to meet the dual imperatives of patient safety and operational efficiency. Strategic supply chain realignment and regional commercialization planning will be essential to navigate cost pressures while maintaining clinical performance standards.

As organizations translate these insights into procurement and R&D roadmaps, the emphasis must remain on evidence-based device selection and the integration of lifecycle support services that reduce complication rates and total procedural burden. By aligning product development, distribution strategy, and clinician enablement, device manufacturers and health systems can collaboratively advance vascular access care while managing evolving regulatory and economic constraints.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripherally Inserted Central Catheter Market, by Product Type

  • 8.1. Open Ended Coaxial
    • 8.1.1. Multi Lumen
    • 8.1.2. Single Lumen
  • 8.2. Power Injectable
    • 8.2.1. Multi Lumen
    • 8.2.2. Single Lumen
  • 8.3. Valved Coaxial
    • 8.3.1. Multi Lumen
    • 8.3.2. Single Lumen

9. Peripherally Inserted Central Catheter Market, by Material

  • 9.1. Polyurethane
    • 9.1.1. Antimicrobial Coated
    • 9.1.2. Standard Polyurethane
  • 9.2. Silicone
    • 9.2.1. Antithrombogenic Coated
    • 9.2.2. Standard Silicone

10. Peripherally Inserted Central Catheter Market, by Indication

  • 10.1. Antibiotic Therapy
    • 10.1.1. Long Term Therapy
    • 10.1.2. Short Term Therapy
  • 10.2. Chemotherapy
    • 10.2.1. Hematological Therapy
    • 10.2.2. Solid Tumor Therapy
  • 10.3. Infusion Therapy
    • 10.3.1. Critical Care Infusion
    • 10.3.2. Hydration Therapy
    • 10.3.3. Pain Management Infusion
  • 10.4. Parenteral Nutrition
    • 10.4.1. Partial Parenteral Nutrition
    • 10.4.2. Total Parenteral Nutrition

11. Peripherally Inserted Central Catheter Market, by End User

  • 11.1. Ambulatory Surgery Centers
    • 11.1.1. Hospital Affiliated Centers
    • 11.1.2. Independent Centers
  • 11.2. Dialysis Centers
    • 11.2.1. Hospital Based
    • 11.2.2. Standalone
  • 11.3. Home Care Settings
    • 11.3.1. Home Infusion Services
    • 11.3.2. Skilled Nursing Facilities
  • 11.4. Hospitals
    • 11.4.1. Community Hospitals
    • 11.4.2. Specialty Hospitals

12. Peripherally Inserted Central Catheter Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
    • 12.1.1. External Pharmacies
    • 12.1.2. In House Pharmacies
  • 12.2. Online Sales
    • 12.2.1. Direct Manufacturer
    • 12.2.2. Distributor Platforms
  • 12.3. Retail Pharmacies
    • 12.3.1. Chain Pharmacies
    • 12.3.2. Independent Pharmacies

13. Peripherally Inserted Central Catheter Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Peripherally Inserted Central Catheter Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Peripherally Inserted Central Catheter Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Peripherally Inserted Central Catheter Market

17. China Peripherally Inserted Central Catheter Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. AngioDynamics, Inc.
  • 18.6. B. Braun Melsungen AG
  • 18.7. Becton Dickinson and Company
  • 18.8. Cook Medical LLC
  • 18.9. ICU Medical, Inc.
  • 18.10. Medical Components, Inc.
  • 18.11. Medtronic plc
  • 18.12. Merit Medical Systems, Inc.
  • 18.13. PFM Medical, Inc.
  • 18.14. Poly Medicure Ltd.
  • 18.15. Smiths Group plc
  • 18.16. Teleflex Incorporated
  • 18.17. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MULTI LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SINGLE LUMEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIMICROBIAL COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIMICROBIAL COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIMICROBIAL COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTITHROMBOGENIC COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTITHROMBOGENIC COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTITHROMBOGENIC COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDARD SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY LONG TERM THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY LONG TERM THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY LONG TERM THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SHORT TERM THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SHORT TERM THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SHORT TERM THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HEMATOLOGICAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HEMATOLOGICAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HEMATOLOGICAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SOLID TUMOR THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SOLID TUMOR THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SOLID TUMOR THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CRITICAL CARE INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CRITICAL CARE INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CRITICAL CARE INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HYDRATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HYDRATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HYDRATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PAIN MANAGEMENT INFUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARTIAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARTIAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARTIAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL AFFILIATED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDALONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME INFUSION SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME INFUSION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME INFUSION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SKILLED NURSING FACILITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SKILLED NURSING FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SKILLED NURSING FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY EXTERNAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY EXTERNAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY EXTERNAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY IN HOUSE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY IN HOUSE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY IN HOUSE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIRECT MANUFACTURER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIRECT MANUFACTURER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIRECT MANUFACTURER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTOR PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTOR PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTOR PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POLYURETHANE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY SILICONE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ANTIBIOTIC THERAPY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY CHEMOTHERAPY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY INFUSION THERAPY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DIALYSIS CENTERS, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY OPEN ENDED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY POWER INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY VALVED COAXIAL, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE PERIPHERALLY INSERTED CENTRAL CATHETER MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE PERIPHERALLY INSER